News and Reports
-
Allena Pharmaceuticals Presents Phase 1 Data on ALLN-177
17 November 2014Download -
Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals
30 October 2014Download -
Probiodrug raises €22 5 million in successful Initial Public Offering and listing on Euronext Amsterdam
23 October 2014Download -
Nabriva Therapeutics Receives FDA Fast Track Status For Lefamulin
8 October 2014Download -
Probiodrug plans IPO on Euronext Amsterdam
25 September 2014Download -
PTC Therapeutics prepares for commercial launch of Translarna
17 September 2014Download -
Ophthotech reports Fovista effects on sub-retinal fibrosis in wet AMD
16 September 2014Download -
Kolltan data for KTN3379 support combinations with targeted therapies
15 September 2014Download -
Kolltan files for IPO
12 September 2014Download -
AAA Acquires GE Healthcare’s FDG-PET Radiopharmaceutical Business in Italy
11 September 2014Download -
i-Optics and Ophtec collaborate in cataract and refractive surgery market
10 September 2014Download -
Kolltan acquires Xetrios Therapeutics
9 September 2014Download -
Ophthotech achieves first milestone under Novartis agreement
8 September 2014Download -
Delenex Presents Clinical Data on Topical Application of PENTRABodies
2 September 2014Download -
CardiacAssist Receives FDA Clearance for PROTEK Cannula
28 August 2014Download -
Ellipse Technologies? Revolutionary Spinal Deformity Treatment for Children on Display at IMAST this Week
17 July 2014Download -
HOYA and i-Optics enter into global partnership with novel eye care test for consumers
14 July 2014Download -
Pacira Pharmaceuticals, Inc. Announces Publication of Pooled Results from IMPROVE Studies Evaluating Health Economic Benefits of EXPAREL®
26 June 2014Download -
Basilea’s oncology drug candidate BAL101553 shows first evidence of antitumor activity in phase 1 study
2 June 2014Download -
PTC Therapeutics receives positive opinion from CHMP for Translarna? (ATALUREN)
23 May 2014Download -
Ophthotech Corporation Announces Closing of Registered Public Offering of Common Stock Including Full Exercise of Underwriters? Option to Purchase Additional Shares
19 May 2014Download -
Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450
8 May 2014Download -
Pacira Pharmaceuticals, Inc. Announces sNDA Submission for EXPAREL Nerve Block Indication
7 May 2014Download -
Curetis Launches Unyvero™ i60 Implant and Tissue Infection Cartridge in Europe
7 May 2014Download -
New Favorable Clinical Evaluation Data for Unyvero™ P50 Pneumonia Application
23 April 2014Download